Q2 2021 Immunovia AB (publ) Earnings Call Transcript
Welcome to the Immunovia Audiocast Teleconference Q2 2021. (Operator Instructions) I'll now hand the floor to CEO, Patrik Dahlen. Please begin your meeting.
()-
Good afternoon, everyone. Thanks for joining us today, and thank you for your continued interest in Immunovia. Today's quarterly report presentation is a historical one as it is the first presentation as a commercial company.
We have now passed a pivotal milestone in the company's history. Immunovia Inc. has launched IMMray PanCan-d as a laboratory-developed test in the U.S. This is a major achievement for all of us here at Immunovia and provides an opportunity for doctors, patients and their relatives to access the first blood test for early detection of pancreatic cancer. It is truly groundbreaking.
My name is Patrik Dahlen. I am the CEO of Immunovia, and I will be presenting the quarter 2, 2021 results for Immunovia. Together with me on the call is also our Medical Director, Dr. Thomas King; and Cindy Callahan, our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |